Alkami Technology, Inc. (ALKT) Misses Q4 EPS by 8c

Alkami Technology, Inc. (NASDAQ: ALKT) reported Q4 EPS of ($0.15), $0.08 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $42.4 million versus the consensus estimate of $41.02 million.

GUIDANCE:

Alkami Technology, Inc. sees FY2022 revenue of $188-192 million, versus the consensus of $189 million.

For earnings history and earnings-related data on Alkami Technology, Inc. (ALKT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c